explore -WSS

explore

author：Wikipedia 2025-10-01 22:59:38 - browse：1166

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Some top drug companies are starting to take action on climate

WSS

10 million people disenrolled from Medicaid over past six months

6 solutions to address cancer drug shortages and others

Study points to new risk in gene therapy death of Terry Horgan

The new shift in health care is toward less care

Will an HIV vaccine ever be a reality?

FDA approves Recor Medical high blood pressure device

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Alkermes shareholders re

Study: New antibiotic targets gonorrhea as well as last existing drug

Activists slam private health insurers over coverage restrictions

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

How to save PrEP access — and even expand it

European officials brace for rough respiratory virus season

State Dept. review finds Biden bears some blame for Afghanistan failures

Free speech concerns arise in wake of journal editor Eisen's firing

Malaria cases in Florida and Texas: Here’s what you need to know

Abortion clinic in Cancun will cater to Americans

explore

Victims of gun violence feel impacts long after bullet wound

The United States is paying nearly triple for new Covid vaccines

Diversify hospital leadership teams to protect BIPOC patient health

Senate panel clears PBM, hopsital reforms

Study: New antibiotic targets gonorrhea as well as last existing drug

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

knowledge

knowledge

Wikipedia

Wikipedia